Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.Clin Infect Dis. 2020; 71: 905-913
- Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.Clin Chest Med. 2015; 36: 13-34
- Epidemiology of CF: How registries can be used to advance our understanding of the CF population.J cystic fibrosis : official J Eur Cystic Fibrosis Soc. 2018; 17: 297-305
Cystic_Fibrosis_Foundation_Patient_Registry. 2020 Annual Data Report, Bethesda, MD. 2021. Available at: https://www.cff.org/sites/default/files/2021-11/Patient-Registry-Annual-Data-Report.pdf
- Epidemiology of pulmonary nontuberculous mycobacterial sputum positivity in patients with cystic fibrosis in the United States, 2010-2014.Ann Am Thorac Soc. 2018; 15: 817-826
- Mycobacterial isolations in young adults with cystic fibrosis.Thorax. 1984; 39: 369-375
- Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Research Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.Am J Respir Crit Care Med. 2003; 167: 828-834
- Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. Multicenter Study Support, 2009 Research Support, Non-U.S. Gov't.J Clin Microbiol. 2009; 47: 4124-4128
- Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. Research Support, N.I.H., Extramural.J Cystic Fibrosis. 2010; 9: 117-123
- Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.Curr Opin Pulm Med. 2013; 19: 662-669
- Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.J cystic fibrosis. 2014; 14: S1569-S1993
- Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.Respir Res. 2014; 15: 41https://doi.org/10.1186/1465-9921-15-41
- Increasing nontuberculous mycobacteria infection in cystic fibrosis.J cystic fibrosis : official J Eur Cystic Fibrosis Soc. 2015; 14: 53-62
- Increased prevalence and resistance of important pathogens recovered from respiratory specimens of cystic fibrosis patients during a decade.Pediatr Infect Dis J. 2015; 34: 700-705
- Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.Am J Respir Crit Care Med. 2012; 185: 881-886
- Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.Am J Respir Crit Care Med. 2010; 182: 970-976
- Mycobacterial testing trends, United States, 2009-2015(1).Emerg Infect Dis. 2020; 26: 2243-2246
- Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. Managed care health plan, 2008-2015.Ann Am Thorac Soc. 2020; 17: 178-185
- Nontuberculous mycobacteria in patients with cystic fibrosis.Semin Respir Crit Care Med. 2013; 34: 124-134
- Infection in cystic fibrosis: impact of the environment and climate.Expert Rev Respir Med. 2016; 10: 505-519
- Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.Clin Infect Dis. 2015; 60: 703-712
- Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.Am J Respir Crit Care Med. 2014; 190: 175-184
- Changes in the cystic fibrosis airway Microbiome in response to CFTR modulator therapy.Front Cell Infect Microbiol. 2021; 11: 548613https://doi.org/10.3389/fcimb.2021.548613
- The impact of CFTR modulator therapies on CF airway microbiology.J cystic fibrosis. 2020; 19: 359-364
- Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections.Am J Respir Crit Care Med. 2017; 195: 1617-1628
- Cystic fibrosis Foundation (U.S.) patient registry. 2019 annual data report.(Available at:)
- Twelve years of progressive Mycobacterium abscessus lung disease in CF-Response to Trikafta.Pediatr Pulmonol. 2021; 56: 4048-4050
- Prospective analysis of the effect of highly effective modulator therapy on prevalence of positive cultures for nontuberculous mycobacterial infection in the PREDICT trial.J Cystic Fibrosis. 2021;
- Nontuberculous mycobacteria among cystic fibrosis patients in the United States: screening practices and environmental risk.Am J Respir Crit Care Med. 2014; https://doi.org/10.1164/rccm.201405-0884OC
Cystic Fibrosis Australia. Australian Cystic Fibrosis Registry: Annual Report 2019. Available at: https://www.cysticfibrosis.org.au/CysticFibrosis/media/CFQ/Media%20Releases/CFQ-Annual-Report-2019.pdf
- Trends in nontuberculous mycobacteria infection in children and young people with cystic fibrosis.J cystic fibrosis. 2020; https://doi.org/10.1016/j.jcf.2020.09.007
- Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. Research Support, Non-U.S. Gov't.J Clin Microbiol. 2005; 43: 3467-3470
- Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients.Ann Clin Microbiol Antimicrob. 2014; 13: 28https://doi.org/10.1186/1476-0711-13-28
- Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.J cystic fibrosis. 2015; 14: 46-52
- High prevalence of nontuberculous mycobacteria in cystic fibrosis patients in tropical French Reunion Island.Pediatr Infect Dis J. 2021; 40: e120-e122
- Prevalence and clinical outcomes of nontuberculous mycobacteria in a Brazilian cystic fibrosis reference center.Pathog Dis. 2018; 76https://doi.org/10.1093/femspd/fty051
- Prospective study of mycobacterial infections in patients with cystic fibrosis.Thorax. 1990; 45: 397-400
- Nontuberculous mycobacterial infection in young children with cystic fibrosis. Research Support, N.I.H., Extramural Support and AuthorAnonymous, Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.Pediatr Pulmonology. 2005; 40: 39-44
- Mycobacterium abscessus and children with cystic fibrosis. Research Support, Non-U.S. Gov't.Emerging Infect Dis. 2003; 9: 1587-1591
- Non-tuberculous mycobacteria in cystic fibrosis.Thorax. 1998; 53: 182-185
- Mycobacterial lung disease in cystic fibrosis: a prospective study.Pediatr Infect Dis J. 1997; 16: 354-358
- The role of Mycobacteria Other than Tuberculosis (MOTT) in patients with cystic fibrosis. Research Support, Non-U.S. Gov't.Scand J Infect Dis. 1994; 26: 569-576
- A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.Hum Gene Ther. 2001; 12: 1907-1916
- Nontuberculous mycobacteria in adult patients with cystic fibrosis. Case Reports Research Support, U.S. Gov't, P.H.S.Chest. 1992; 102: 70-75
- Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Multicenter Study.Emerging Infect Dis. 2008; 14: 378-384
Registro Brasileiro de Fibrose Cística (REBRAFC). 2019 Patient Registry. Available at: http://rebrafc.org.br.
CF Registry of Ireland. 2019 Annual Report. 2020. Available at: https://cfri.ie/annual-reports/
- European cystic fibrosis society. ECFS patient Regsitry annual data report.(Available at:)
- Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.Am J Respir Crit Care Med. 2005; 171: 621-626
- Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study.J Infect Chemother : official J Jpn Soc Chemother. 2016; 22: 526-531
- Phylogenomics of Brazilian epidemic isolates of Mycobacterium abscessus subsp. bolletii reveals relationships of global outbreak strains.Infect Genet Evol : J Mol Epidemiol Evol Genet Infect Dis. 2013; 20: 292-297
- High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks.Emerg Infect Dis. 2014; 20: 364-371
- Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study.Lancet. 2013; 381: 1551-1560
- Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.Science. 2016; 354: 751-757
- Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy.Eur Respir J. 2017; 50https://doi.org/10.1183/13993003.02525-2016
- Cross-transmission is not the source of new Mycobacterium abscessus infections in a multicenter cohort of cystic fibrosis patients.Clin Infect Dis. 2020; 70: 1855-1864
- Genomic analysis of Mycobacterium abscessus complex isolates collected in Ireland between 2006 and 2017.J Clin Microbiol. 2020; : 58https://doi.org/10.1128/JCM.00295-20
- Investigating transmission of Mycobacterium abscessus amongst children in an Australian cystic fibrosis centre.J cystic fibrosis. 2020; 19: 219-224
- Population genomics of Mycobacterium abscessus from United States cystic fibrosis care centers.Ann Am Thorac Soc. 2021; https://doi.org/10.1513/AnnalsATS.202009-1214OC
- Genomic epidemiology of a national outbreak of post-surgical Mycobacterium abscessus wound infections in Brazil.Microb Genom. 2017; 3e000111
- Global phylogenomic analyses of Mycobacterium abscessus provide context for non cystic fibrosis infections and the evolution of antibiotic resistance.Nat Commun. 2021; 12: 5145
- Genomic characterization of sporadic isolates of the dominant clone of Mycobacterium abscessus subspecies massiliense.Scientific Rep. 2021; 1115336
- Dissemination of Mycobacterium abscessus via global transmission networks.Nat Microbiol. 2021; 6: 1279-1288
- Population genomics and Inference of Mycobacterium avium complex clusters in cystic fibrosis care centers, United States.Emerg Infect Dis. 2021; 27: 2836-2846
- Comparative genomics of Mycobacterium avium complex reveals Signatures of environment-specific adaptation and Community acquisition.mSystems. 2021; 6: e0119421
- Whole genome sequencing of Nontuberculous Mycobacterium (NTM) isolates from sputum specimens of co-habiting patients with NTM pulmonary disease and NTM isolates from their environment.BMC genomics. 2020; 21: 322
- Mycobacterium avium in Community and household water, Suburban Philadelphia, Pennsylvania, USA, 2010-2012.Emerg Infect Dis. 2019; 25: 473-481
- Mycobacterium avium complex diversity within lung disease, as revealed by whole-genome sequencing.Am J Respir Crit Care Med. 2019; 200: 393-396
- Stepwise pathogenic evolution of Mycobacterium abscessus.Science. 2021; : 372
- Children with cystic fibrosis are infected with multiple subpopulations of Mycobacterium abscessus with different antimicrobial resistance Profiles.Clin Infect Dis. 2019; 69: 1678-1686
- Whole-genome sequencing for predicting clarithromycin resistance in Mycobacterium abscessus.Antimicrob Agents Chemother. 2019; 63https://doi.org/10.1128/AAC.01204-18
- Improved performance predicting clarithromycin resistance in Mycobacterium abscessus on an independent data set.Antimicrob Agents Chemother. 2019; 63https://doi.org/10.1128/AAC.00400-19
- Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Research Support, U.S. Gov't, P.H.S.Chest. 1993; 103: 1096-1099
- Risk factors for nontuberculous mycobacterial isolation in patients with cystic fibrosis: a meta-analysis.Pediatr Pulmonol. 2020; 55: 2653-2661
- Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis.Chest. 2010; 137: 1157-1163
- Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.Am J Respir Crit Care Med. 2010; 182: 614-626
- Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.Chest. 2006; 130: 995-1002
- Nontuberculous mycobacterial infection: CT scan findings, genotype, and treatment responsiveness.Comp Study Chest. 2005; 128: 3863-3869
- Association of CFTR gene variants with nontuberculous mycobacterial lung disease in a Korean population with a low prevalence of cystic fibrosis.J Hum Genet. 2013; 58: 298-303
- Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Research Support, N.I.H., Extramural Support, 2006 Research Support, Non-U.S. Gov't.Thorax. 2006; 61: 507-513
- Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. Research Support, Non-U.S. Gov't.J cystic fibrosis. 2013; 12: 74-80
- Azithromycin and the risk of nontuberculous mycobacteria in adults with cystic fibrosis. Conference Abstract.Pediatr Pulmonology. 2011; 46: 328
- A retrospective review of non-tuberculous mycobacteria in paediatric cystic fibrosis patients at a regional centre. Conference Abstract.J Cystic Fibrosis. 2011; 10: S36
- Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France.Med Mycol. 2010; 48: S32-S36
- Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.Pediatr Pulmonol. 2017; 52: 324-330
- Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.Eur Respir J. 2005; 25: 324-328
- Mycobacterium abscessus in cystic fibrosis: what does it all mean? Conference Abstract.Clin Microbiol Infect. 2011; 17: S602
- Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection.ERJ Open Res. 2021; 7https://doi.org/10.1183/23120541.00578-2020
- Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment.J Appl Microbiol. 2009; 107: 356-367
- Vitamin D deficiency is associated with increased nontuberculous mycobacteria risk in cystic fibrosis.Ann Am Thorac Soc. 2021; 18: 913-916
- Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. Research Support, Non-U.S. Gov't.J Clin Invest. 2011; 121: 3554-3563
- Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.Am J Respir Crit Care Med. 2013; 188: 807-812
- Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.J cystic fibrosis : official J Eur Cystic Fibrosis Soc. 2015; 14: 594-599
- Chronic azithromycin Use in cystic fibrosis and risk of treatment-Emergent respiratory pathogens.Ann Am Thorac Soc. 2018; 15: 702-709
- Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients.Eur Respir J. 2013; 41: 1101-1106
- [Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study]. Multicenter Study.Archivos de Bronconeumologia. 2008; 44 (Estudio multicentrico de prevalencia de micobacterias ambientales en pacientes con fibrosis quistica): 679-684
- Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors.Pediatr Pulmonology. 2009; 44: 1100-1106
- Environmental risks for nontuberculous mycobacteria: individual exposures and climatic factors in the Cystic Fibrosis population.Ann Am Thorac Soc. 2014; https://doi.org/10.1513/AnnalsATS.201404-184OC
- Nontuberculous mycobacterial infection and environmental molybdenum in persons with cystic fibrosis: a case-control study in Colorado.J Expo Sci Environ Epidemiol. 2021; https://doi.org/10.1038/s41370-021-00360-2
- Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida.PLoS One. 2021; 16e0259964
- Spatial clusters of nontuberculous mycobacterial lung disease in the United States.Am J Respir Crit Care Med. 2012; https://doi.org/10.1164/rccm.201205-0913OC
- Nontuberculous mycobacterial disease and molybdenum in Colorado watersheds.Int J Environ Res Public Health. 2020; 17https://doi.org/10.3390/ijerph17113854
- NTM infection risk and trace Metals in Surface water: a population-based Ecologic epidemiologic study in Oregon.Ann Am Thorac Soc. 2021; https://doi.org/10.1513/AnnalsATS.202101-053OC
- Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.Am J Respir Crit Care Med. 2003; 167: 835-840
- Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis.Acta Paediatr. 2003; 92: 910-915
- Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis. Comparative Study Support, 2004 Research Support, Non-U.S. Gov't.Med Microbiol Immunol. 2004; 193: 209-217
- Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Research Support, N.I.H., Extramural.Ann Am Thorac Soc. 2014; 11: 36-44
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.Thorax. 2016; 71: i1-i22
- Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Clinical Trial Multicenter, Multicenter Study Support, 1997 Research Support, Non-U.S. Gov't.J Clin Microbiol. 1997; 35: 2706-2708
- Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis.Eur J Clin Microbiol Infect Dis : official Publ Eur Soc Clin Microbiol. 2002; 21: 546-548
- Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis.J Clin Microbiol. 1993; 31: 861-864
- Nontuberculous mycobacteria in patients with cystic fibrosis.Clin Infect Dis. 2001; 32: 1298-1303
- Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review.Lancet Infect Dis. 2006; 6: 664-674
- Diagnosis of nontuberculous mycobacterial infections.Clin Lab Med. 2002; 22 (vi): 911-925
- Culturing mycobacteria.Methods Mol Biol. 2021; 2314: 1-58
- Comparison of NaOH-N-acetyl cysteine and sulfuric acid decontamination methods for recovery of mycobacteria from clinical specimens.J Microbiol Methods. 2005; 62: 83-88
- Recovery of mycobacteria from patients with cystic fibrosis.J Clin Microbiol. 1999; 37: 3761-3763
- Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis. Eval Stud Support, Non-U.S. Gov't.J Clin Microbiol. 2006; 44: 2237-2239
- Evaluation of RGM medium for isolation of nontuberculous mycobacteria from respiratory samples from patients with cystic fibrosis in the United States.J Clin Microbiol. 2017; 55: 1469-1477
- A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis.J cystic fibrosis : official J Eur Cystic Fibrosis Soc. 2016; 15: 186-191
- Comparison of MALDI-TOF MS with HPLC and nucleic acid sequencing for the identification of Mycobacterium species in cultures using solid medium and broth.Am J Clin Pathol. 2014; 141: 25-34
- Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes.3rd edition. CLSI standard document M24, Wayne, PA, USA2018
- An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Practice Guideline Review.Am J Respir Crit Care Med. 2007; 175: 367-416
- Impact of susceptibility to Injectable Antibiotics on the treatment outcomes of Mycobacterium abscessus pulmonary disease.Open Forum Infect Dis. 2021; 8: ofab215https://doi.org/10.1093/ofid/ofab215
- A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.Antimicrob Agents Chemother. 2009; 53: 1367-1376
- Natural and acquired macrolide resistance in mycobacteria.Curr Drug Targets Infect Disord. 2002; 2: 355-370
- Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.Am J Respir Crit Care Med. 2006; 174: 928-934
- Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers.J cystic fibrosis : official J Eur Cystic Fibrosis Soc. 2020; 19: 569-574
- Disseminated Mycobacterium gordonae infection in a child with cystic fibrosis.Pediatr Pulmonology. 2012; 47: 517-518
- [Nontuberculous mycobacteria in patients with cystic fibrosis].Medicina. 1998; 58 (Microbacterias no tuberculosas en pacientes con fibrosis quistica): 257-261
- Detection of Mycobacterium abscessus from deep pharyngeal swabs in cystic fibrosis.Infect Control Hosp Epidemiol. 2015; 36: 618-619
- Development of multiplex PCR assays based on the 16S-23S rRNA internal transcribed spacer for the detection of clinically relevant nontuberculous mycobacteria.Lett Appl Microbiol. 2011; 52: 546-554
- Development of a simple and low-cost real-time PCR method for the identification of commonly encountered mycobacteria in a high throughput laboratory.J Appl Microbiol. 2009; 107: 1433-1439
- Detection of mycobacterial DNA from sputum of patients with cystic fibrosis. Research Support, Non-U.S. Gov't.Irish J Med Sci. 2004; 173: 96-98
- Skin reactivity to atypical mycobacteria in cystic fibrosis. Research Support, Non-U.S. Gov't.Respir Med. 1990; 84: 273-276
- Measurement of immunoglobulin G against Mycobacterial antigen A60 in patients with cystic fibrosis and lung infection due to Mycobacterium abscessus. Research Support, Non-U.S. Gov't.Clin Infect Dis. 2005; 40: 58-66
- Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis.Eur Respir J. 2015; 46: 707-716
- Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study.BMC Infect Dis. 2014; 14: 655https://doi.org/10.1186/s12879-014-0655-4
- Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway.J Cystic Fibrosis. 2020; https://doi.org/10.1016/j.jcf.2020.06.016
- The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.Am J Respir Crit Care Med. 2012; https://doi.org/10.1164/rccm.201204-0682OC
- Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial. Multicenter Study. Randomized Controlled Trial. Support, 2006 Research Support, Non-U.S. Gov't.Thorax. 2006; 61: 895-902
- Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Clinical Trial Randomized Controlled Trial.Lancet. 2002; 360: 978-984
- Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.JAMA. 2003; 290: 1749-1756
- Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Clinical Trial Randomized Controlled Trial Support, 2002 Research Support, Non-U.S. Gov't.Thorax. 2002; 57: 212-216
- Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.Chest. 2014; 146: 276-282
- Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.Am J Respir Crit Care Med. 2015; 191: 96-103
- Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease. Case Reports Support, 1999 Research Support, Non-U.S. Gov't.Eur Respir J. 1999; 14: 347-351
- Nontuberculous mycobacteria in the setting of cystic fibrosis. Review.Clin Chest Med. 2002; 23: 655-663
- The genome sequence of 'Mycobacterium massiliense' strain CIP 108297 suggests the independent taxonomic status of the Mycobacterium abscessus complex at the subspecies level.PLoS One. 2013; 8e81560
- Treatment of Mycobacterium abscessus pulmonary disease.Chest. 2022; 161: 64-75
- Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.J cystic fibrosis : official J Eur Cystic Fibrosis Soc. 2015; 14: 63-69
- Therapeutic drug monitoring in the treatment of tuberculosis.Drugs. 2002; 62: 2169-2183
- Introduction to pharmacokinetics: aminoglycosides in cystic fibrosis as a prototype.J Pediatr. 1986; 108: 847-853
- Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.Clin Pharmacokinet. 1987; 13: 228-253
- Drug disposition in cystic fibrosis.Clin Pharmacokinet. 1998; 35: 313-329
- Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosis.J cystic fibrosis : official J Eur Cystic Fibrosis Soc. 2021; https://doi.org/10.1016/j.jcf.2021.04.011
- Beyond antibiotics for pulmonary nontuberculous mycobacterial disease.Curr Opin Pulm Med. 2020; 26: 260-266
- Inhaled granulocyte-macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis.Eur Respir J. 2018; 51https://doi.org/10.1183/13993003.02127-2017
- Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infection and immunity.Oct. 2000; 68: 5619-5627
- Non-nuberculous mycobacteria infection treated with intermittently inhaled high-dose nitric oxide.BMJ Case Rep. 2021; : 14https://doi.org/10.1136/bcr-2021-243979
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.Nat Med. 2019; 25: 730-733
- Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection.Nat Med. 2021; 27: 1357-1361
- Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.Am J Respir Crit Care Med. 2009; 180: 896-902
- Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease.Clin Infect Dis. 2011; 52: 565-571
- Surgical approach to pulmonary nontuberculous mycobacterial infections.Clin Chest Med Mar. 2015; 36: 117-122
- Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study.Arch Dis Child. 2022; 107: 479-485
- Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. Research Support, Non-U.S. Gov't.J Clin Microbiol. 2007; 45: 1497-1504
- Outcome according to subspecies following lung transplantation in cystic fibrosis pediatric patients infected with Mycobacterium abscessus.Transpl Infect Dis : official J Transplant Soc. 2020; 22e13274
- Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. Case Reports.J Heart Lung Transplant. 2006; 25: 985-988
- Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence. Case Reports.Transpl Infect Dis. 2009; 11: 243-248
- Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.J Clin Microbiol. 2001; 39: 816-819
- Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence.Transpl Infect Dis : official J Transplant Soc. 2009; 11: 243-248
- Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection. Case Reports Support, 2010 Research Support, Non-U.S. Gov't.J cystic fibrosis : official J Eur Cystic Fibrosis Soc. 2010; 9: 272-276
- Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: a single center experience.Transpl Infect Dis : official J Transplant Soc. 2019; 21e13084
- Infectious complications of lung transplantation. Impact of cystic fibrosis.Am J Respir Crit Care Med. 1994; 149: 1601-1607
- Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections.Clin Transpl. 2013; 27: 523-529
- Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population.Transpl Proc. 2013; 45: 342-345
- Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series.Transpl Infect Dis. 2019; 21e13046
- Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species.Eur Respir J. 2013; 41: 1230-1232
- Non-tuberculous mycobacteria in lung transplant recipients: prevalence, risk factors, and impact on survival and chronic lung allograft dysfunction.Transpl Infect Dis. 2020; 22: e13229
- A consensus document for the selection of lung transplant candidates: 2014--an update from the pulmonary transplantation Council of the international society for Heart and lung transplantation.J Heart Lung Transplant. 2015; 34: 1-15
- Evaluation of infections in the lung transplant patient.Curr Opin Infect Dis. 2012; 25: 193-198
- NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice.BMC Pulm Med. 2018; 18: 86
- Lung transplant referral for individuals with cystic fibrosis: cystic Fibrosis Foundation consensus guidelines.J cystic fibrosis : official J Eur Cystic Fibrosis Soc. 2019; 18: 321-333
- Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic.Clin Infect Dis. 2001; 32: 1648-1650
- Molecular Fingerprinting of Mycobacterium abscessus strains in a cohort of pediatric cystic fibrosis patients.J Clin Microbiol. 2012; 50: 1758-1761
- Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Letter.Am J Respir Crit Care Med. 2012; 185: 231-232
- Antimicrobial susceptibility and Phylogenetic Relations in a German cohort infected with Mycobacterium abscessus.J Clin Microbiol. 2020; 58https://doi.org/10.1128/JCM.01813-20
- Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of mycobacterium abscessus in a cohort of pediatric cystic fibrosis patients.Clin Infect Dis. 2015; 60: 1007-1016
- Infection prevention and control guideline for cystic fibrosis: 2013 update.Infect Control Hosp Epidemiol. 2014; 35
- Prevention of transmission of Mycobacterium abscessus among patients with cystic fibrosis.Curr Opin Pulm Med. 2019; https://doi.org/10.1097/MCP.0000000000000621
- Healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (HALT NTM) study: Rationale and study design.PLoS One. 2021; 16: e0261628
- Investigating nontuberculous mycobacteria transmission at the Colorado adult cystic fibrosis program.Am J Respir Crit Care Med. 2022; https://doi.org/10.1164/rccm.202108-1911OC
- Genomic analysis of a hospital-associated outbreak of Mycobacterium abscessus: implications on transmission.J Clin Microbiol. 2021; : JCM0154721https://doi.org/10.1128/JCM.01547-21
- Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs.Respir Med. 2009; 103: 1448-1455
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
